Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels

2022/06/13 by Erika Cecon, Daniela Fernandois, Nicolas Renault +13 · 1 voice · 1 citation
Medicine · Neuroscience · Psychology · #COVID-19 and Mental Health #Circadian rhythm and melatonin #Long-Term Effects of COVID-19

paper · pdf · doi:10.1007/s00018-022-04390-3

openalex publication_date 2022/06/13 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
• Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
• Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
• Structural basis of receptor recognition by SARS-CoV-2
• A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
• Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
• Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
• Post-acute COVID-19 syndrome
• Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial

Cited by

• A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)

Discussions

• Hier ein paar Quellen, die ich abgespeichert habe (gibt wahrscheinlich auch noch Neueres): "Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels" [bsky, 14 points, 2 comments]